QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies CLYM Q1 2026 Earnings NarrowerThanExpected Loss Supports Positive Investor Sentiment OCUL Q1 2026 Earnings WiderthanExpected Loss but Stock Gains on Pipeline Progress CRVS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline UVV Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Slips CIEN Q1 2026 Earnings EPS Surpasses Estimates on Operational Strength